Get notified when TRAX files again. Create a free account and we'll email you the moment its next filing is analyzed.

Get filing alerts
NASDAQ: TRAX First Tracks Biotherapeutics, Inc. 424B3

First Tracks Biotherapeutics registers resale of up to 10.5M shares by selling stockholders; company gets no proceeds

Filed August 13, 2026 · ~1 min read

Key Changes

  • high

    Selling stockholders may sell up to 10,497,054 shares of common stock; the company will not receive any proceeds from these sales.

    The Offering view on EDGAR →

This preview is just the start — the full report includes the narrative summary, section-by-section diffs against the prior filing, and verbatim quotes with EDGAR citations.

Read 3 full reports/month free No card required. Takes 30 seconds.

Want to see a complete report first? Today's free report (MLKN 10-Q) is open in full — no account needed.

Partner

Trade TRAX commission-free

Open an account, get a free stock.

Sign up

Investing involves risk. Free stock terms apply.

Was this report useful?
View original filing on SEC.gov

Figures/quotes linked to EDGAR · Narrative written by AI · Sep 2, 2026 · How we verify